MedPage Today on MSN
Triple Therapy Inhaler Improves Lung Function in Poorly Controlled Asthma
CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta ...
The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR) agonist that mimics the effects of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback